www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Scientific focus
    • Science & technology
    • Pipeline
    • Digital innovation
    • Clinical data sharing
    • Collaboration & partnerships
    • Healthcare Professionals
      • Allergy Immunotherapy
      • Reweal
      • Clinical trials
      • Webinars
      • The Henning Lowenstein Research Award
  • Our company
    • Press
    • Our strategy
    • Our leadership
    • Our history
    • Corporate governance
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Executive Leadership Team
      • Board of Directors
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
      • Capital Markets Day 2024
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
    • Contact IR
    • Annual general meeting
      • Annual general meeting (DK)
    • Capital Markets Day 2024
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024

« Back

ALK-Abelló, grant of share options to members of the Board of Management and senior managers

March 01, 2006

PDF Version

The Board of Directors passed a resolution to grant share options to the members of the Board of Management and a number of senior managers of ALK-Abelló as part of a retention program. 75,000 options will be granted, divided into 6,000 options to each of the five members of the Board of Management and 45,000 shares to a group of senior managers.

The options can be exercised during the period from January 1, 2009 to January 1, 2012 during the four-week trading window following the release of annual and interim reports. If the option holders have not exercised their options within the period specified, the options will lapse without any compensation to the holders. The options will lapse on termination of employment.

The exercise price of the options will be determined as the average of the officially quoted price of the Company’s shares (the average price on the Copenhagen Stock Exchange) during the period March 1 – March 14, 2006 (both days included). To this should be added annual interest at the rate of 6%, which will be added the first time on January 1, 2007. The exercise price of the options will be adjusted on payment of dividend, to the effect that DKK 1 of dividend per share results in a reduction of the exercise price by 1 DKK.

The market value of the adopted option plan of 75,000 options is approximately DKK 14 million applying the Black & Scholes model for valuation of options. In the determination of the value, the assumed exercise price of DKK 947 per share is based on a share price of DKK 750, no dividend distribution, a volatility rate of 35% p.a. and a risk-free interest rate of 3.33% p.a.

Under the international financial reporting standards (IFRS), the option plan will be recognized in the income statement under costs in the respective functional areas over the vesting period.

The grant of share options does not change the Company’s financial forecast for the full year.

No options have been granted to members of the Board of Directors.

 

 

Hørsholm, March 1, 2006

ALK-Abelló A/S

Jørgen Worning

Chairman

Contact:

Jørgen Worning, Chairman of the Board of Directors, tel +45 4576 7405

  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved